RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 60 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2013. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $404,000 | +136.3% | 45,000 | +41.1% | 0.00% | – |
| Q2 2016 | $171,000 | -89.1% | 31,894 | -89.4% | 0.00% | -100.0% |
| Q4 2015 | $1,570,000 | -42.4% | 302,062 | -32.9% | 0.00% | -33.3% |
| Q3 2015 | $2,724,000 | -22.8% | 450,159 | +101.5% | 0.00% | 0.0% |
| Q2 2015 | $3,528,000 | +286.0% | 223,425 | +165.7% | 0.00% | +200.0% |
| Q1 2015 | $914,000 | +2.0% | 84,094 | -1.3% | 0.00% | 0.0% |
| Q4 2014 | $896,000 | -12.0% | 85,195 | -19.8% | 0.00% | 0.0% |
| Q3 2014 | $1,018,000 | +19.9% | 106,191 | +44.4% | 0.00% | 0.0% |
| Q2 2014 | $849,000 | -3.6% | 73,538 | -16.5% | 0.00% | 0.0% |
| Q1 2014 | $881,000 | +313.6% | 88,116 | +439.6% | 0.00% | – |
| Q4 2013 | $213,000 | +395.3% | 16,330 | +255.4% | 0.00% | – |
| Q2 2013 | $43,000 | – | 4,595 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |